Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    Febrile Seizures
Show Display Options
Rank Status Study
1 Completed Antipyretics for Preventing Recurrences of Febrile Seizures
Condition: Recurrence of Febrile Seizure
Intervention: Drug: Diclofenac, Paracetamol, Ibuprofen
2 Terminated Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Condition: Febrile Seizure
Interventions: Drug: Carbogen;   Drug: Placebo
3 Unknown  Respiratory Physiology in Children With Febrile Seizures.
Conditions: Febrile Illness in Children;   Seizures, Febrile
Intervention:
4 Completed Nervous System Infections Among Patients With Febrile Seizure
Conditions: Seizure;   Febrile Seizure;   Meningitis;   Encephalitis
Intervention:
5 Completed The Relevance of Performing Lumbar Puncture in Infants Aged 3 to 12 Months With First Episode of Febrile Convulsion
Condition: Febrile Convulsions
Intervention:
6 Completed METHORIVAC - Vaccinal Pharmacoepidemiologic
Condition: Infants Likely to Present Febrile Convulsions
Intervention:
7 Active, not recruiting Copeptin in Childhood Epilepsy
Conditions: Epilepsy;   Febrile Seizures;   Children
Intervention:
8 Unknown  Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age
Conditions: Bronchiolitis;   Gastroenteritis;   Convulsion, Febrile
Intervention:
9 Completed Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV
Condition: Fever
Interventions: Other: Acetaminophen;   Other: Placebo
10 Completed The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
Condition: Fever
Interventions: Drug: Acetaminophen Arm;   Drug: Placebo Arm;   Drug: Ibuprofen Arm
11 Terminated Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies
Conditions: Parkinson's Disease;   Epilepsy
Intervention:
12 Completed
Has Results
Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.
Conditions: Prospective;   Single-blind;   Clinical;   Trial;   Intervention
Intervention: Biological: BCG-vaccine (SSI)
13 Withdrawn Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
Conditions: Mumps;   Rubella;   Measles;   Varicella
Interventions: Biological: Priorix-Tetra™;   Other: Safety data collection
14 Completed
Has Results
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)
Conditions: Bacterial Infections;   Virus Diseases
Interventions: Biological: V419;   Biological: DAPTACEL™;   Biological: PedvaxHIB™;   Biological: Prevnar 13™;   Biological: RotaTeq™;   Biological: PENTACEL™;   Biological: Recombivax HB vaccine;   Biological: ActHIB™
15 Completed Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Conditions: Measles;   Varicella;   Mumps;   Rubella
Interventions: Biological: PriorixTM;   Biological: VarilrixTM;   Biological: GSK Biologicals' vaccine 208136
16 Completed
Has Results
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Conditions: Rubella;   Mumps;   Measles
Interventions: Biological: GSK Biological's investigational vaccine 209762;   Biological: M-M-R® II (Merck and Co);   Biological: Varivax®;   Biological: Havrix®;   Biological: Prevnar®
17 Completed Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Conditions: Measles;   Varicella;   Mumps;   Rubella
Interventions: Biological: Priorix-Tetra TM (combined measles-mumps-rubella-varicella vaccine);   Biological: GSK Biologicals' 208136, new formulation
18 Active, not recruiting
Has Results
Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
Condition: Infections, Papillomavirus
Interventions: Biological: Cervarix;   Biological: Priorix;   Biological: Infanrix
19 Recruiting A Surveillance Study of Diseases Specified as Adverse Events of Specific Interest (AESI) and Serious Adverse Events (SAEs) in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Condition: Malaria
Interventions: Procedure: Lumbar puncture;   Procedure: Venous blood sample
20 Completed Utility of Laboratory Testing for Children With Seizure in Emergency Department
Condition: Seizure
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.